Aleniglipron

GSBR-1290 · Gasherbrum Bio, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Aleniglipron, covering 2025-09-15 to 2026-04-27. Get the full timeline:

Most recent: Clinical Trial Update: Aleniglipron Phase 2 in Type 2 Diabetes Mellitus [Phase 2]